Association of polypharmacy and potential drug‐drug interactions with adverse treatment outcomes in older adults with advanced cancer

Background Polypharmacy is common in older adults who are starting cancer treatment and is associated with an increased risk of potentially inappropriate medications (PIMs) and potential drug‐drug interactions (PDIs). The authors evaluated the association of medication measures with adverse outcomes...

Ausführliche Beschreibung